Enovix CorporationENVXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P26
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.85% |
| Q3 2025 | 0.11% |
| Q2 2025 | 8.56% |
| Q1 2025 | 15.58% |
| Q4 2024 | -7.38% |
| Q3 2024 | -16.67% |
| Q2 2024 | -40.43% |
| Q1 2024 | 41.08% |
| Q4 2023 | 156.01% |
| Q4 2023 | -18.40% |
| Q3 2023 | -30.30% |
| Q2 2023 | 52.78% |
| Q4 2022 | 11.45% |
| Q4 2022 | -11.87% |
| Q3 2022 | 24.32% |
| Q2 2022 | 2.36% |
| Q4 2021 | 20.74% |
| Q4 2021 | 8.17% |
| Q2 2021 | 70.39% |
| Q1 2021 | 11.78% |
| Q4 2020 | 31.34% |
| Q3 2020 | 17.86% |
| Q2 2020 | 34.30% |
| Q1 2020 | 0.00% |